Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site study.
In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said.
“Now we can start to predict which drugs a patient will respond to,” said co-senior author Harris Perlman, chief of rheumatology at Northwestern University Feinberg School of Medicine. “We can truly do precision medicine for rheumatoid arthritis. I believe this could be game changing. ”
The paper was recently published as an uncorrected proof in Arthritis & Rheumatology and will be officially published in the journal in late May. Richard Pope and Deborah Winter also are lead Northwestern authors.
Treatment for rheumatoid arthritis now is trial and error.
“We have so many different biologic drugs and there’s no rhyme or reason to give one drug versus the other,” Perlman said. “We waste $2.5 billion a year in ineffective therapy. And patients go through 12 weeks of therapy, don’t respond and get upset.”
Scientists in the multi-site study were the first in the U.S. to use ultrasound-guided therapy to take a tissue biopsy in the affected joint. In the past, blood samples were used to try to determine the effectiveness of the therapy and disease progression.
“It’s just like oncology, where you go to the tumor,” Perlman said. “Why go anywhere else? In rheumatoid arthritis, we’ve never gone to the target organ.”
Improved ultrasound guided techniques make the new technique possible, Perlman said, noting joint biopsies began in Europe about six years ago.
Scientists in the six-site study analyzed the tissue in 41 rheumatoid arthritis patients, separating out different immune cell populations. They focused on macrophages, essentially the garbage collectors of the immune system that are overactive in rheumatoid arthritis. These cells produce toxic, inflammatory proteins that destroy the joints. Biologic therapy removes the protein molecules being secreted by the macrophages.
The study included 30 patients from Northwestern and the remaining 11 from the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.
In the past, scientists have tried to determine therapeutic effectiveness by separating patients into groups based on their clinical parameters such as what antibodies they are producing against themselves, how swollen their joints are and medications they are taking. Then scientists tried to see if these parameters could predict therapeutic efficacy. But that hasn’t worked, Perlman said.
Instead, Perlman and colleagues segregated patients based on the genes being produced by their macrophages. They identified two patient groups who shared aspects of the genetic profiles.
Next, the scientists identified which of these patient populations had joints that were getting better and what biologic therapies they were taking. They also identified a gene sequence associated in patients with early disease. The earlier the patient is treated, the more effective the therapy.
The next goal is to predict which patients will have the best response — based on their genetic signature — to a specific drug.
In a new study, researchers are taking joint biopsy tissue from patients at the start of a new therapy and then six weeks later to see if they can find a predictor gene sequence that will clearly identify which patients respond to a particular therapy.
“The idea is to develop gene sequences to predict whether a patient will respond or not,” Perlman said. “Our goal is that this procedure will become the standard of care of for all patients with rheumatoid arthritis.”
Learn more: Rheumatoid arthritis meets precision medicine
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
- BRIEF-Abbvie Says NDA Accepted For Priority Review By U.S. FDA For Upadacitinib For Treatment Of Moderate To Severe Rheumatoid Arthritis on February 19, 2019 at 5:47 am
* ABBVIE - NDA FOR UPADACITINIB FOR TREATING MODERATE TO SEVERE RHEUMATOID ARTHRITIS IS SUPPORTED BY DATA FROM GLOBAL UPADACITINIB SELECT PHASE 3 PROGRAM * ABBVIE - UPADACITINIB IS ALSO UNDER REVIEW B... […]
- New hope for arthritis sufferers? on February 19, 2019 at 5:34 am
A daily pill called APPA which is claimed to be ‘game-changing’ for treating rheumatoid arthritis, could be made available for millions of Britons. Scientists are testing the drug on humans after find... […]
- Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis on February 18, 2019 at 2:49 am
Rheumatoid Arthritis (RA) is a chronic inflammatory disorder where incidence and severity of myocardial infarction are increased. Data on the incidence and outcome of stroke are conflicting. Thus, we ... […]
- Study: Cranberry Juice May Decrease Inflammation in Women with Rheumatoid Arthritis on February 14, 2019 at 12:59 pm
Paraná, Brazil—A study conducted on the effects of cranberry juice in women with rheumatoid arthritis (RA) provides evidence that cranberry juice can be beneficial for decreasing the disease activity ... […]
- Treat your Rheumatoid Arthritis with board-certified doctors at The Polyclinic on February 13, 2019 at 8:42 pm
SEATTLE — Living with Rheumatoid arthritis or any autoimmune, inflammatory or arthritic condition can be complex in the least. The Polyclinic's Rheumatology department cuts through the confusion with ... […]
- Four Stages and Progression of Rheumatoid Arthritis on February 11, 2019 at 11:31 am
Rheumatoid arthritis (RA) affects different people in different ways. It can be mild, moderate, or severe, and symptoms vary from person to person. There’s no exact timeline for the progression of RA. ... […]
- Rheumatoid Arthritis and Mental Health: What You Need to Know on February 11, 2019 at 11:30 am
Rheumatoid arthritis (RA) has many physical symptoms. But those living with RA may also experience mental health issues that may be related to the condition. Mental health refers to your emotional and ... […]
- Bacteria in milk, beef may be linked to rheumatoid arthritis on February 8, 2019 at 1:32 am
Milk is good for bones, but joints are another story for some people, according to a new study. A strain of bacteria commonly found in milk and beef may be a trigger for developing rheumatoid arthriti... […]
- Surprise Rheumatoid Arthritis Discovery Points to New Treatment for Joint Inflammation on February 7, 2019 at 6:26 am
People suffering from rheumatoid arthritis may soon have a way to help alleviate its symptoms. The medical breakthrough is thanks to research done at the University of Virginia, in collaboration with ... […]
via Bing News